Evaluation of Anticoagulation Parameters After Discontinuation of Argatroban in Critically Ill Patients.
Class of 2015 Abstract === Objectives: Argatroban is the current drug of choice for type II heparin induced thrombocytopenia. Primarily metabolized by the liver, this direct thrombin inhibitor has a volume of distribution of approximately 174 mLs per kg. While few studies suggested no differences in...
| Main Authors: | , , , |
|---|---|
| Language: | en_US |
| Published: |
The University of Arizona.
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/614113 http://arizona.openrepository.com/arizona/handle/10150/614113 |